Presentations
Presentations
Apr 27, 2023
Apr 27, 2023
Apr 27, 2023
Apr 27, 2023
Apr 27, 2023
Apr 18, 2023
Apr 17, 2023
Apr 13, 2023
Mar 30, 2023
Mar 14, 2023
Feb 27, 2023
Feb 21, 2023
Feb 08, 2023
Jan 11, 2023
Jan 09, 2023
Dec 19, 2022
Dec 12, 2022
Dec 12, 2022
Dec 10, 2022
Dec 10, 2022
Nov 10, 2022
Nov 10, 2022
Nov 01, 2022
Oct 27, 2022
Oct 05, 2022
Sep 29, 2022
Sep 27, 2022
Sep 06, 2022
Aug 08, 2022
Jun 21, 2022
Jun 12, 2022
Jun 11, 2022
Jun 11, 2022
May 16, 2022
May 09, 2022
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results
May 05, 2022
Apr 27, 2022
Apr 21, 2022
Apr 20, 2022
Apr 20, 2022
Apr 20, 2022
Apr 11, 2022
Mar 22, 2022
Mar 08, 2022
CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research
Feb 15, 2022
Feb 09, 2022
CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Nov 16, 2021
CRISPR Therapeutics and ViaCyte to Start Clinical Trial of the First Gene Edited Cell Replacement
Nov 08, 2021
Nov 03, 2021
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
Nov 02, 2021
Oct 14, 2021
Oct 12, 2021
Oct 12, 2021
Oct 01, 2021
Sep 28, 2021
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
Aug 05, 2021
CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference
Jul 29, 2021
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
Jun 11, 2021
Jun 11, 2021
May 06, 2021
Apr 27, 2021
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
Apr 10, 2021
Apr 06, 2021
CRISPR Therapeutics to Participate in the 20th Annual Needham Virtual Healthcare Conference
Mar 10, 2021
Mar 09, 2021
Mar 04, 2021
Feb 16, 2021
Feb 05, 2021
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
Feb 01, 2021
CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer
Feb 01, 2021
Jan 04, 2021
Dec 14, 2020
CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
Dec 09, 2020
Dec 06, 2020
Nov 24, 2020
CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 16, 2020
CRISPR Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
Oct 21, 2020
Oct 07, 2020
Jul 27, 2020
Jul 27, 2020
Jun 15, 2020
Apr 07, 2020
Apr 02, 2020
Mar 18, 2020
Nov 19, 2019
